Closing price as of 2026-06-12 · Source: TEK2day Finance
1-Year Price History-2.6% over period
Key Metrics
Market Cap
$55.2M
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Want live quotes, estimates, SEC filings, and CEO analytics for TIL? The free TEK2day terminal runs in your browser — type /TIL to get started.